ATE536101T1 - Behandlung heilmittelresistenter proliferativer erkrankungen - Google Patents

Behandlung heilmittelresistenter proliferativer erkrankungen

Info

Publication number
ATE536101T1
ATE536101T1 AT06717284T AT06717284T ATE536101T1 AT E536101 T1 ATE536101 T1 AT E536101T1 AT 06717284 T AT06717284 T AT 06717284T AT 06717284 T AT06717284 T AT 06717284T AT E536101 T1 ATE536101 T1 AT E536101T1
Authority
AT
Austria
Prior art keywords
treatment
drug
proliferative diseases
resistant
resistant proliferative
Prior art date
Application number
AT06717284T
Other languages
English (en)
Inventor
M V Ramana Reddy
E Premkumar Reddy
Stephen Cosenza
Stacey Baker
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Application granted granted Critical
Publication of ATE536101T1 publication Critical patent/ATE536101T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06717284T 2005-01-05 2006-01-04 Behandlung heilmittelresistenter proliferativer erkrankungen ATE536101T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64137805P 2005-01-05 2005-01-05
PCT/US2006/000059 WO2006074149A2 (en) 2005-01-05 2006-01-04 Treatment of drug-resistant proliferative disorders

Publications (1)

Publication Number Publication Date
ATE536101T1 true ATE536101T1 (de) 2011-12-15

Family

ID=36648100

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06717284T ATE536101T1 (de) 2005-01-05 2006-01-04 Behandlung heilmittelresistenter proliferativer erkrankungen

Country Status (9)

Country Link
US (1) US20090306207A1 (de)
EP (1) EP1841420B1 (de)
JP (1) JP5156389B2 (de)
KR (2) KR101427105B1 (de)
AT (1) ATE536101T1 (de)
AU (1) AU2006204103B2 (de)
CA (1) CA2593523C (de)
IL (1) IL184292A (de)
WO (1) WO2006074149A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090197893A1 (en) * 2005-12-01 2009-08-06 Bristol-Myers Squibb Company Methods of Identifying and Treating Individuals Exhibiting Complex Karyotypes
KR101707669B1 (ko) * 2008-04-17 2017-02-16 더 존스 홉킨스 유니버시티 약제-내성 종양에서 화학요법제 활성을 증강시키는 ｏｎ01910.ｎａ
JP6348904B2 (ja) 2012-09-20 2018-06-27 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイションＴｅｍｐｌｅ Ｕｎｉｖｅｒｓｉｔｙ−Ｏｆ Ｔｈｅ Ｃｏｍｍｏｎｗｅａｌｔｈ Ｓｙｓｔｅｍ Ｏｆ Ｈｉｇｈｅｒ Ｅｄｕｃａｔｉｏｎ 置換アルキルジアリール誘導体、その製造方法及び使用
US10383831B2 (en) 2015-08-03 2019-08-20 Temple University—Of the Commonwealth System of Higher Education 2,4,6-trialkoxystryl aryl sulfones, sulfonamides and carboxamides, and methods of preparation and use
CN111926086B (zh) * 2020-08-21 2022-05-31 云南农业大学 一种影响鸡体斜长的分子标记及其应用
GB2628229A (en) * 2021-08-12 2024-09-18 Onconova Therapeutics Inc Methods and compositions for treating cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2210601C2 (ru) * 1996-07-25 2003-08-20 Ипкор Н.В. Способ восстановления и плавления металла
BR9814059B1 (pt) * 1997-10-03 2010-08-24 composto e composiÇço farmacÉutica.
US6548553B2 (en) * 1997-10-03 2003-04-15 Temple University-Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
EP1173160B1 (de) * 1999-04-02 2005-06-22 Temple University of the Commonwealth System of Higher Education (e)-styrylsulfone als krebsbestreitende mittel
US6762207B1 (en) * 1999-04-02 2004-07-13 Temple University - Of The Commonwealth System Of Higher Education (E)-styryl sulfone anticancer agents
US6767926B1 (en) * 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
US6243322B1 (en) * 1999-11-05 2001-06-05 Wavemakers Research, Inc. Method for estimating the distance of an acoustic signal
US6541475B2 (en) * 2000-04-14 2003-04-01 Temple University - Of The Commonwealth System Of Higher Education α, β-unsaturated sulfones for treating proliferative disorders
US6486210B2 (en) * 2000-04-14 2002-11-26 Temple University—Of the Commonwealth System of Higher Education Substituted styryl benzylsulfones for treating proliferative disorders
ATE406881T1 (de) * 2001-02-28 2008-09-15 Univ Temple Verwendung von alpha, beta ungesättigten arylsulfonen zum schutz von zellen und geweben vor toxizität ionischer strahlung
JP4538233B2 (ja) * 2002-02-28 2010-09-08 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 増殖性障害治療用の、アミノ置換されたスルホンアニリド及びその誘導体
KR100972131B1 (ko) * 2002-02-28 2010-07-26 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 증식성 질병 치료용 아미노-치환（ｅ）-2,6-디알콕시스티릴 4-치환-벤질설폰
DK1689706T3 (da) * 2003-11-14 2017-04-03 Temple Univ - Of The Commonwealth System Of Higher Education Alfa, beta-umættede sulfoxider til behandling af proliferative forstyrrelser
US7932242B2 (en) * 2004-03-16 2011-04-26 Temple University - Of The Commonwealth System Of Higher Education Substituted phenoxy-and phenylthio-derivatives for treating proliferative disorders

Also Published As

Publication number Publication date
US20090306207A1 (en) 2009-12-10
WO2006074149A3 (en) 2007-11-15
KR20070094956A (ko) 2007-09-27
EP1841420A2 (de) 2007-10-10
EP1841420A4 (de) 2009-12-09
AU2006204103A1 (en) 2006-07-13
EP1841420B1 (de) 2011-12-07
IL184292A (en) 2012-10-31
AU2006204103B2 (en) 2011-11-24
KR101427105B1 (ko) 2014-08-07
JP2008526852A (ja) 2008-07-24
WO2006074149A2 (en) 2006-07-13
JP5156389B2 (ja) 2013-03-06
IL184292A0 (en) 2007-10-31
KR20130091796A (ko) 2013-08-19
CA2593523A1 (en) 2006-07-13
CA2593523C (en) 2014-04-08

Similar Documents

Publication Publication Date Title
EA202092899A1 (ru) Гетероарильные соединения для лечения болезни гентингтона
DK2150530T3 (da) Substituerede sulfonamid-derivater
EA200900983A1 (ru) Соединения и композиции в качестве ингибиторов киназы
DOP2009000141A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteína quinasa
CR10072A (es) Derivados de pirimidinil-aril-urea que son inhibidores de fgf
MX383856B (es) Compuestos y composiciones para inhibir la actividad de shp2.
DK1625126T3 (da) Imidazo- og thiazolopyridiner som JAK3-kinaseinhibitorer
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA200970156A1 (ru) Пиридизиноновые производные
EA200801362A1 (ru) Пиримидинил бензотиофеновые соединения
EA201100447A1 (ru) Органические соединения
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
EA200700489A1 (ru) Новые бензоконденсированные гетероарилсульфамидные производные, полезные в качестве противоконвульсивных средств
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
EA201500403A1 (ru) Соединения, активирующие теломеразу, и способы их применения
NO20092130L (no) Tricykliske heteroarylforbindelser anvendelige som inhibitorer of januskinase
MA32505B1 (fr) 5-alcynyl-pyrimidines
CO6630193A2 (es) Inhibidores de la actividad de la proteína tirosina quinasa seleccionada
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
ATE502935T1 (de) C-met-proteinkinasehemmer
IL184292A0 (en) Treatment of drug-resistant proliferative disorders